Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Soininen, P. (Pasi)"'
Autor:
Männistö, V. (Ville), Kaminska, D. (Dorota), Kärjä, V. (Vesa), Tiainen, M. (Mika), de Mello, V. D. (Vanessa D.), Hanhineva, K. (Kati), Soininen, P. (Pasi), Ala‐Korpela, M. (Mika), Pihlajamäki, J. (Jussi)
Background & Aims: Alterations in liver phosphatidylcholine (PC) metabolism have been implicated in the pathogenesis of non‐alcoholic fatty liver disease (NAFLD). Although genetic variation in the phosphatidylethanolamine N‐methyltransferase (PEM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::681d41d4229f0000cb99159560d51199
http://urn.fi/urn:nbn:fi-fe2019111943209
http://urn.fi/urn:nbn:fi-fe2019111943209
Autor:
Delles, C. (Christian), Rankin, N. J. (Naomi J.), Boachie, C. (Charles), McConnachie, A. (Alex), Ford, I. (Ian), Kangas, A. (Antti), Soininen, P. (Pasi), Trompet, S. (Stella), Mooijaart, S. P. (Simon P.), Jukema, J. W. (J. Wouter), Zannad, F. (Faiez), Ala‐Korpela, M. (Mika), Salomaa, V. (Veikko), Havulinna, A. S. (Aki S.), Welsh, P. (Paul), Würtz, P. (Peter), Sattar, N. (Naveed)
Aims: We investigated the association between quantified metabolite, lipid and lipoprotein measures and incident heart failure hospitalisation (HFH) in the elderly, and examined whether circulating metabolic measures improve HFH prediction. Methods a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::fd93bf02475497edb7bf4a0e085d8124
http://urn.fi/urn:nbn:fi-fe2018082333986
http://urn.fi/urn:nbn:fi-fe2018082333986
Autor:
Akbaraly, T. (Tasnime), Würtz, P. (Peter), Singh-Manoux, A. (Archana), Shipley, M. J. (Martin J.), Haapakoski, R. (Rita), Lehto, M. (Maili), Desrumaux, C. (Catherine), Kähönen, M. (Mika), Lehtimäki, T. (Terho), Mikkilä, V. (Vera), Hingorani, A. (Aroon), Humphries, S. E. (Steve E.), Kangas, A. J. (Antti J.), Soininen, P. (Pasi), Raitakari, O. (Olli), Ala-Korpela, M. (Mika), Kivimäki, M. (MIka)
Diet may modify metabolomic profiles towards higher or lower cardiovascular disease (CVD) risk. We aimed to identify metabolite profiles associated with high adherence to dietary recommendations — the Alternative Healthy Eating Index (AHEI) — and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::2adc3d5cdce529c66928e35ad57f87d2
http://urn.fi/urn:nbn:fi-fe2018081633724
http://urn.fi/urn:nbn:fi-fe2018081633724
Autor:
Kaikkonen, J. E. (Jari E.), Würtz, P. (Peter), Suomela, E. (Emmi), Lehtovirta, M. (Miia), Kangas, A. J. (Antti J.), Jula, A. (Antti), Mikkilä, V. (Vera), Viikari, J. S. (Jorma S.A.), Juonala, M. (Markus), Rönnemaa, T. (Tapani), Hutri-Kähönen, N. (Nina), Kähönen, M. (Mika), Lehtimäki, T. (Terho), Soininen, P. (Pasi), Ala-Korpela, M. (Mika), Raitakari, O. T. (Olli T.)
Nonalcoholic fatty liver is associated with obesity-related metabolic disturbances, but little is known about the metabolic perturbations preceding fatty liver disease. We performed comprehensive metabolic profiling to assess how circulating metaboli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::18eca64629cdf12a05ade4a6f8fe2f0c
http://urn.fi/urn:nbn:fi-fe201703245835
http://urn.fi/urn:nbn:fi-fe201703245835
Autor:
Würtz, P. (Peter), Kangas, A. J. (Antti J.), Soininen, P. (Pasi), Lawlor, D. A. (Debbie A.), Smith, G. D. (George Davey), Ala-Korpela, M. (Mika)
Detailed metabolic profiling in large-scale epidemiologic studies has uncovered novel biomarkers for cardiometabolic diseases and clarified the molecular associations of established risk factors. A quantitative metabolomics platform based on nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::91edca84a334d6f248eb3d34659e65e6
http://urn.fi/urn:nbn:fi-fe201801182109
http://urn.fi/urn:nbn:fi-fe201801182109
Autor:
Davis, J. P. (James P.), Huyghe, J. R. (Jeroen R.), Locke, A. E. (Adam E.), Jackson, A. U. (Anne U.), Sim, X. (Xueling), Stringham, H. M. (Heather M.), Teslovich, T. M. (Tanya M.), Welch, R. P. (Ryan P.), Fuchsberger, C. (Christian), Narisu, N. (Narisu), Chines, P. S. (Peter S.), Kangas, A. J. (Antti J.), Soininen, P. (Pasi), Ala-Korpela, M. (Mika), Kuusisto, J. (Johanna), Collins, F. S. (Francis S.), Laakso, M. (Markku), Boehnke, M. (Michael), Mohlke, K. L. (Karen L.)
Lipid and lipoprotein subclasses are associated with metabolic and cardiovascular diseases, yet the genetic contributions to variability in subclass traits are not fully understood. We conducted single-variant and gene-based association tests between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::00b14723286c72d03653187a8ebb6bd5
http://urn.fi/urn:nbn:fi-fe2017120555338
http://urn.fi/urn:nbn:fi-fe2017120555338
Autor:
I. S. (Ilkka Seppälä), Oksala, N. (Niku), Jula, A. (Antti), Kangas, A. J. (Antti J.), Soininen, P. (Pasi), Hutri-Kähönen, N. (Nina), März, W. (Winfried), Meinitzer, A. (Andreas), Juonala, M. (Markus), Kähönen, M. (Mika), Raitakari, O. T. (Olli T.), Lehtimäki, T. (Terho)
High L-homoarginine (hArg) levels are directly associated with several risk factors for cardiometabolic diseases whereas low levels predict increased mortality in prospective studies. The biomarker role of hArg in young adults remains unknown. To stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::1593eb5d434d9e931247112dc4c4530b
http://urn.fi/urn:nbn:fi-fe201706287550
http://urn.fi/urn:nbn:fi-fe201706287550
Autor:
Wang, Q. (Qin)
Cardiovascular diseases are the leading cause of death worldwide and type 2 diabetes is reaching a global epidemic. Epidemiological studies have identified numerous risk factors and pharmacotherapies in relation to these cardiometabolic diseases. How
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2423::78f6c3dd17bef4f3dc1c76ca34591bc9
http://urn.fi/urn:isbn:9789526215082
http://urn.fi/urn:isbn:9789526215082